Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825263 | SCV000966553 | likely benign | not specified | 2019-02-12 | criteria provided, single submitter | clinical testing | The p.Val4946Val variant in USH2A is classified as likely benign because it does not alter an amino acid residue, it is not located within the splice consensus sequence, and splice prediction algorithms do not predict a newly created splice site. It has been identified in 0.007% (1/15382) of European chromosomes in gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BP4, BP7. |
Labcorp Genetics |
RCV001449024 | SCV001652129 | likely benign | not provided | 2023-10-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453740 | SCV004182868 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271913 | SCV004182879 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271913 | SCV001453408 | likely benign | Usher syndrome type 2A | 2020-05-01 | no assertion criteria provided | clinical testing |